Warner Bros Discovery's board rejected Paramount Skydance's $108.4 billion hostile bid on Wednesday, saying it failed to provide adequate financing assurances.

On CNBC's “Mad Money Lightning Round,” on Tuesday, Jim Cramer recommended being careful with Lumen Technologies, Inc. (NYSE: LUMN) as the stock has “run too much.”

As electric vehicle (EV) makers have discovered, America runs on gasoline. About 290 million registered vehicles cruise the roads.

DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced that it has entered into a definitive agreement to be acquired by Exclusive Investments LLC (“Exclusive Investments”), the parent company of Exclusive Resorts . Under the terms of the agreement, Exclusive Investments will acquire all outstanding shares of Inspirato for $4.27 per share in an all-cash transaction, valuing Inspirato at an equity value of approximately $59 million on a fully diluted basis. The purchase price represents an approximately 50% premium to Inspirato's closing price on December 16, …

Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain

DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama) and QED Investors. This milestone brings Codoxo's to.

A well-known media and entertainment powerhouse inked a three-year deal with the creator of the most popular large language model. This move demonstrates just how valuable it is to own high-quality intellectual property, which can be monetized in unique ways.

Stocks have been volatile the past few months and that has created opportunities in a few stocks, and in today's video we are going to discuss three stocks that are high on my watch list to buy. One of those stocks is Boeing (BA 0.05%) as it is in the midst of a turnaround story and getting back to producing more output, which will flow to the bottom line and start generating positive free cash flow again.

Key US stocks show signs of strength, with Tesla and Palantir pressing toward breakouts that could support the broader market. Super Micro Computer may be stabilizing, but confirmation is still needed before buyers step in.

ABM Industries (ABM) came out with quarterly earnings of $0.88 per share, missing the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.9 per share a year ago.

Markets are preparing for Europe's central banks to announce their final interest-rate decisions of the year. The European Central Bank, Bank of England, Riksbank and Norges Bank are all concluding monetary policy meetings on Thursday.

Darden Restaurants, Inc. (NYSE: DRI) will release earnings results for its second quarter before the opening bell on Thursday, Dec. 18.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Wednesday it has dosed the first patient in a Phase 2 clinical trial testing its intranasal drug candidate foralumab in patients with early Alzheimer's disease. The randomized, placebo-controlled study will evaluate foralumab as a standalone treatment and in combination with FDA-approved anti-amyloid drugs lecanemab (Leqembi) or donanemab in people with early or mild Alzheimer's, the company said.

Enbridge fits the profile of a SWAN stock, due to its highly contracted and inflation-protected cash flows. ENB has a number of growth projects underway and is set to benefit from strong underlying demand for energy in North America and globally. The valuation remains attractive and the 5.9% dividend yield is well-covered, making it a 'Buy' at present.

TransDigm Group (TDG) earns a buy rating, driven by structural pricing power, visible growth catalysts, and disciplined capital allocation. TDG benefits from proprietary, mission-critical components with high aftermarket exposure, locking in long-duration revenue streams and strong pricing power. Defense demand is robust, with 13% FY25 growth and new program wins, while commercial OEM headwinds are easing as destocking ends.

Gold price holds above $4258.68 as traders watch CPI, with bulls targeting $4353.56 and $4381.44. Key support at $4192.36–$4133.95 keeps the gold market on alert.

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed. If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.